ETF Financing Ranking | Yinhua CSI Innovative Drugs Industry ETF (159992) had a net financing buy-in of CNY 53.7 million, ranked first among comparable funds-20260714

NewTimeSpace (newtimespace.com) News, Jul 14, 2026, Yinhua CSI Innovative Drugs Industry ETF (159992.SZ) increased by 3.54%, had a turnover of CNY 1.53 billion. Obtained financing buy-in of CNY 175.26 million, and financing repayment of CNY 121.56 million, with a net financing buy-in of CNY 53.7 million, ranked first among comparable funds. (Data source: Wind)

Over a longer period, for the past 5 trading days of the fund, there were 3 days with net financing buy-in, totaling CNY 61.4 million, ranked top among comparable funds. (Data source: Wind)

Yinhua CSI Innovative Drugs Industry ETF (159992.SZ), off-exchange connection (A type: 012781; C type: 012782).

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.